Author:
Sebesta Christian,Feichter Alexandra,Selimi Flonza
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Orphanet. https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=877. Zugegriffen: 16. Aug. 2021.
2. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of Neuroendocrine tumors and carcinomas. Neoplasia. 2017;19(12):991–1002.
3. Sansone A, Lauretta R, Vottari S, Chiefari A, et al. Specific and non-specific biomarkers in neuroendocrine gastroenteropancreatic tumors. Cancers. 2019;11(8):1113–8.
4. Klimstra DS, Yang Z. Pathology, classification, and grading of neuroendocrine neoplasms arising in the digestive system. UpToDate. 2019. https://www.uptodate.com/contents/pathology-classification-and-grading-of-neuroendocrine-neoplasms-arising-in-the-digestive-system.
5. Pavel M, Öberg K, Falconi M, Krenning EP, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;6(4):844–60.